ITCA 650-CLP-203

Location: Denver

Stay: None

Gender: Male/Female

Ages: 18-80

Compensation: $60.00

Smokers Allowed: Yes

Study Overview:

This study is being done to see if consistent delivery of Exenatide may lead to better control of blood glucose levels and moderate the risk of comorbidities and complications otherwise associated with inadequately controlled T2D. The study drug is a device placed under the skin that delivers medication (exenatide) consistently for 3 to 6 months.

Enroll In This Study